TAC3: A Protein Potential Drug Target for Heart Failure and Hypertension

Target Name: TAC3

NCBI ID: G6866

TAC3

TAC3: A Protein Potential Drug Target for Heart Failure and Hypertension

TAC3, or Tachykinin-3 (isoform 1), is a protein that is expressed in the heart and is known for its role in heart function. It is a member of the tyrosine kinase family and is involved in the regulation of many different cellular processes in the heart.

One of the things that makes TAC3 so interesting as a potential drug target is its role in heart failure. Heart failure is a condition in which the heart is not able to pump enough blood to meet the needs of the body. This can be caused by a variety of factors, including problems with the heart's electrical activity or problems with the heart's muscle. TAC3 has been shown to be involved in the regulation of the heart's electrical activity and has been shown to play a key role in the development and progression of heart failure.

Another potential drug target for TAC3 is its role in hypertension. Hypertension, or high blood pressure, is a condition in which the pressure on the blood vessels is too high. This can lead to a variety of problems, including heart disease and stroke. TAC3 has been shown to be involved in the regulation of blood pressure and has been shown to play a key role in the development and progression of hypertension.

In addition to its potential as a drug target, TAC3 is also of interest as a biomarker. There are several ways that researchers can use TAC3 as a biomarker for heart failure and hypertension. One way is to use TAC3 as a diagnostic marker for heart failure. Researchers have shown that TAC3 levels are often elevated in the hearts of people with heart failure, and that these levels can be used as a diagnostic marker for this condition. Another way that TAC3 can be used as a biomarker for hypertension is to use it as a target for new treatments. Researchers are currently working on developing drugs that can specifically target TAC3 to treat hypertension.

Overall, TAC3 is a protein that is of great interest as a potential drug target for the treatment of heart failure and hypertension. Its role in the regulation of heart function and its potential as a biomarker make it an attractive target for research into these conditions. Further studies are needed to fully understand the role of TAC3 in these processes and to develop new treatments for heart failure and hypertension.

Protein Name: Tachykinin Precursor 3

Functions: Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles (By similarity). Is a critical central regulator of gonadal function

The "TAC3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TAC3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets